| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.2 | 0.001 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.19 | 0.003 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.006 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.17 | 0.006 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.007 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.092 | 0.008 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.008 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.01 |